Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05687604 · ClinicalTrials.gov registry record · NA

Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

A NA study of Obesity and Smoking Cessation, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target
1
Study location

NCT05687604: Recruiting NA study of Obesity and Smoking Cessation, sponsored by Northwestern University.

NCT05687604 is a NA study of Obesity and Smoking Cessation that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 1,500 participants, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (83% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05687604, a NA study of Obesity and Smoking Cessation, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to improve cancer patient's health, survival, and quality of life by dispelling risk behaviors for Northwestern Memorial Health Care (NMHC) patients who are cancer survivors. The main question\[s\] STELLAR aims to answer are: * How best to combine three behavior interventions (physical activity promotion, smoking cessation, obesity treatment) into one treatment. * Evaluate the reach of the program. We will look at the number, proportion, and representativeness of participants in terms of disease characteristics, socioeconomic status, telehealth readiness, and race/ethnicity. * Evaluate the effects of the STELLAR program relative to enhanced usual care (information provision) on cancer risk behaviors, patient care access, care quality, and communication. Participants will be provided goals related to their physical activity, smoking, and/or weight loss and asked to track their health behaviors via an app, excel file, or on paper. At baseline, 3 months, 6 months and 9 months into the study, participants will provide survey responses and physical measurements like height and weight. Additionally, those in the Facilitated group will complete 12 telehealth sessions with study staff to discuss progress towards their study goals. Researchers will compare the Facilitated group to the Self Guided group to see if the Facilitated intervention group is able to reach more participants that enhances care only.

Primary Outcome

Effectiveness will be primarily evaluated through effects on behavioral change, which will serve as the primary outcomes: For 7-day point-prevalence smoking abstinence at 6 months (self-report of any smoking even a puff in the 7 days before the 6- month follow-up visit). For continuous outcomes (e.g., weight loss) we will use linear regression models adjusting for baseline values. For moderate to vigorous physical activity, the outcome will be transformed (e.g., logarithmically) to stabilize the

Interventions

  • BEHAVIORAL multiple behavior change therapy

Study Locations (1)

Illinois

  • Northwestern University-Feinberg School of Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2024-09-24
Est. Completion 2027-07-31
Phase NA
Northwestern University

1,209 total trials

What NCT05687604 shows while recruiting

NCT05687604 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (83% higher).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which multiple behavior change therapy is the first listed.

NCT05687604 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05687604 about?

NCT05687604 is a clinical study titled "Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors". The goal of this clinical trial is to improve cancer patient's health, survival, and quality of life by dispelling risk behaviors for Northwestern Memorial Health Care (NMHC) patients who are cancer survivors. The main question\[s\] STELLAR aims to answer are: * How best to combine three behavior ...

What is the current status of trial NCT05687604?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2024-09-24. Estimated completion is 2027-07-31.

What conditions does trial NCT05687604 study?

This clinical trial studies the following conditions: Obesity, Smoking Cessation, Physical Inactivity.

What interventions are being tested in trial NCT05687604?

The interventions under investigation include: multiple behavior change therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05687604?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05687604 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05687604's enrollment target sits among peer trials

1,500 55th of 1053 higher than 997 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05687604, the US trial registry maintained by the National Library of Medicine. NCT05687604 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.